Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies
The development of pathogen reduction technologies (PRT) for labile blood components is a long-pursued goal in transfusion medicine. While PRT for red blood cells and whole blood are still in an early phase of development, different PRT platforms for plasma and platelets are commercially available a...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2022-01-01
|
| Serie: | Pathogens |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-0817/11/2/142 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|